Genmab — Maj 2021

[Darvin]

Thanks EL and Nice to see that 4 of the mentioned products are from Genmab

[Bulder]

Og ikke mindre end 4 bcma x cd3 i MM. Her kan man virkelig tale om konkurrence.

[Bulder]

Ligesom der også er trængsel på cd20 x cd3-området.

[GeorgeBest]

Pyt, hvis man den bedste...

[Sukkeralf]

....og den første helst

[Sukkeralf]

Der måtte gerne komme mere samarbejde i stil med immatics, så har man target for sig selv - det er selvfølgelig mere omfattende, men kan give helt unikke produkter

[E_L]

from March, PRV-015 in the EMA paper mill - Human anti-interleukin-15 (IL-15) monoclonal antibody, EMEA-002775-PIP01-20, from Provention
Bio, Inc., for the treatment of coeliac disease; The PDCO adopted positive opinions for product-specific waivers, recommending that the obligation to
submit data obtained through clinical studies with children be waived in all subsets of the paediatric
population

[Helge_LarsenPI-redaktør]

Servicemeddelese: Jeg har i dag overtaget 21 aktionær-aktiegrupper på Facebook. Forude forestår et større arbejde med implementeringen i Proinvestors univers . Det glæder jeg mig til at starte på sammen med et team af unge studerende på CBS og Syddansk Universitet.

[Stroka]

Du er for vild Helge. God nat og sov godt når du kommer så langt.

[deleted-user]

Godmorgen og tillykke Helge. Du kan helt sikkert drive det vidt med de andre unge mennesker. De studerende får brug for dit energiske drive

[E_L]

[Helge_LarsenPI-redaktør]

God morgen.

[Helge_LarsenPI-redaktør]

Onsdagens aviser med Danske Bank, Novo Nordisk og Nordea

Just a moment...

(www.proinvestor.com)

[Helge_LarsenPI-redaktør]

Tak Stroka og LLi.

[E_L]

The Lancet- Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00103-4/fulltext https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00139-3/fulltext

[Bulder]

safety looks worrying. Good genmab came out of that.

[Sukkeralf]

Did anyone buy Lava Therapeutics after they went public (Paul Parren head of R&D) or just me - they have their first investor presentation tonight.

[Sukkeralf]

https://ir.lavatherapeutics.com/news-events/events

[Sukkeralf]

They focus on BsTCE but on the more specific Gamma-Delta T-cell thats more specialized for fighting cancer

[E_L]

JNJ presser on ASCO abstract -Updated Data Demonstrate Significant Improvement in Haematologic Complete Response with DARZALEX▼ (daratumumab) Subcutaneous (SC) Formulation in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis - https://www.businesswire.com/news/home/20210526005626/en/Updated-Data-Demonstrate-Significant-Improvement-in-Haematologic-Complete-Response-with-DARZALEX▼-daratumumab-Subcutaneous-SC-Formulation-in-Patients-with-Newly-Diagnosed-Light-Chain-AL-Amylo